Supplemental material
Current Medical Research and Opinion
Volume 37, 2021 - Issue 6
Cardiovascular Medicine
Real-world effectiveness and safety of rivaroxaban versus warfarin among non-valvular atrial fibrillation patients with obesity in a US population
, 
, , , , , & show all
François Lalibertéb Groupe d’analyse, Ltée, Québec, Canadahttps://orcid.org/0000-0003-2601-6214View further author information
https://orcid.org/0000-0003-2601-6214View further author information, , Dominique Lejeuneb Groupe d’analyse, Ltée, Québec, CanadaCorrespondence[email protected]
https://orcid.org/0000-0002-0981-0486View further author information
https://orcid.org/0000-0002-0981-0486View further author information, Kenneth Todd Moored Janssen Pharmaceuticals, Inc, Titusville, NJ, USAhttps://orcid.org/0000-0001-7505-102XView further author information
https://orcid.org/0000-0001-7505-102XView further author information, , & Veronica Ashtonc Janssen Scientific Affairs, LLC, Titusville, NJ, USAhttps://orcid.org/0000-0003-4880-1897View further author information
https://orcid.org/0000-0003-4880-1897View further author information show all